These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11522620)

  • 1. Loss of annexin II heavy and light chains in prostate cancer and its precursors.
    Chetcuti A; Margan SH; Russell P; Mann S; Millar DS; Clark SJ; Rogers J; Handelsman DJ; Dong Q
    Cancer Res; 2001 Sep; 61(17):6331-4. PubMed ID: 11522620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
    Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C; Henrique R; Hoque MO; Mambo E; Ribeiro FR; Varzim G; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Clin Cancer Res; 2004 Dec; 10(24):8472-8. PubMed ID: 15623627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Kang JS; Calvo BF; Maygarden SJ; Caskey LS; Mohler JL; Ornstein DK
    Clin Cancer Res; 2002 Jan; 8(1):117-23. PubMed ID: 11801547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA.
    Banerjee AG; Liu J; Yuan Y; Gopalakrishnan VK; Johansson SL; Dinda AK; Gupta NP; Trevino L; Vishwanatha JK
    Mol Cancer; 2003 Oct; 2():34. PubMed ID: 14613585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation.
    Ahmed H; Banerjee PP; Vasta GR
    Biochem Biophys Res Commun; 2007 Jun; 358(1):241-6. PubMed ID: 17481580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.
    Liu JW; Shen JJ; Tanzillo-Swarts A; Bhatia B; Maldonado CM; Person MD; Lau SS; Tang DG
    Oncogene; 2003 Mar; 22(10):1475-85. PubMed ID: 12629510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ezrin in prostatic intraepithelial neoplasia.
    Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
    Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
    Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP
    Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate.
    Louis SN; Wang L; Chow L; Rezmann LA; Imamura K; MacGregor DP; Casely D; Catt KJ; Frauman AG; Louis WJ
    Cancer Detect Prev; 2007; 31(5):391-5. PubMed ID: 18031950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.
    Nägler DK; Krüger S; Kellner A; Ziomek E; Menard R; Buhtz P; Krams M; Roessner A; Kellner U
    Prostate; 2004 Jul; 60(2):109-19. PubMed ID: 15162377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer.
    Vallbo C; Wang W; Damber JE
    BJU Int; 2004 Jun; 93(9):1339-43. PubMed ID: 15180634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
    Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
    Shiina H; Breault JE; Basset WW; Enokida H; Urakami S; Li LC; Okino ST; Deguchi M; Kaneuchi M; Terashima M; Yoneda T; Shigeno K; Carroll PR; Igawa M; Dahiya R
    Cancer Res; 2005 Mar; 65(6):2130-8. PubMed ID: 15781623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
    Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC
    Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
    Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
    Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional epigenomics identifies genes frequently silenced in prostate cancer.
    Lodygin D; Epanchintsev A; Menssen A; Diebold J; Hermeking H
    Cancer Res; 2005 May; 65(10):4218-27. PubMed ID: 15899813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.